
A Food and Drug Administration (FDA) advisory panel on Thursday recommended updating COVID-19 jabs this fall to target the “XFG variant.”
Eight out of nine panel members voted in favor of the recommendation, while one abstained.
FDA advisory panel back to its old ways?
Trending: CBS Axes Two Prominent Figures, Adds ‘Outsider’ Executive Producer in Big ’60 Minutes’ Shakeup
Eight out of nine panel members voted in favor of the recommendation, while one abstained.
“According to the Centers for Disease Control and Prevention’s COVID dashboard, new data is currently unavailable…”
“We can’t make a… pic.twitter.com/IiIGQr5LBM
— Jefferey Jaxen (@JeffereyJaxen) May 29, 2026
NBC News has more:
The recommendation — from the FDA’s Vaccines and Related Biological Products Advisory Committee — is meant to help vaccine makers prepare shots for the fall and winter, when Covid infections typically rise.
Thursday’s meeting was the agency’s first since FDA Commissioner Marty Makary resigned. (His resignation did not play a role; the meeting was already on the calendar before he resigned.) Makary drew criticism last
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!